{"disease":{"id":"sickle-beta-thalassemia","name":"sickle beta thalassemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05799118","title":"Study of the Role of Genetic Modifiers in Hemoglobinopathies","phase":"","overall_status":"RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Cyprus Institute of Neurology and Genetics","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT06831799","title":"ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":684,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT05506358","title":"Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada","phase":"NA","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"University of British Columbia","has_results":true},{"nct_id":"NCT03376893","title":"Epidemiology of Silent and Overt Strokes in Sickle Cell Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":102,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT04691323","title":"The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":68,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":false},{"nct_id":"NCT02998450","title":"A Study of IMR-687 in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Cardurion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT05357482","title":"Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":40,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT04688411","title":"An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":false},{"nct_id":"NCT04678037","title":"Home-based Assessment of PRO Measures in SCD Using A Smartphone App Platform: A Feasibility Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":false},{"nct_id":"NCT02179359","title":"Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies","phase":"NA","overall_status":"TERMINATED","enrollment_count":38,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT03763656","title":"Pharmacokinetics of Oral Hydroxyurea Solution","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Nova Laboratories Limited","has_results":true},{"nct_id":"NCT04675645","title":"Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":false},{"nct_id":"NCT05904093","title":"Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT05736419","title":"A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT04099966","title":"AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Mitchell Cairo","has_results":false},{"nct_id":"NCT05675436","title":"Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT03653338","title":"T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":5,"lead_sponsor_name":"Paul Szabolcs","has_results":false},{"nct_id":"NCT04776850","title":"Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies","phase":"EARLY_PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}